NCT05897788
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
Active, Not Recruiting
NAAges 18+InterventionalSupportive careUniversity of PennsylvaniaInvestigator-initiated
~1,808 participants
Updated 2026-07-13 on ClinicalTrials.gov
What's tested:Text Message Check-insContingency Management
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Engagement in any addiction treatment at 30 days of randomization
Measured over 31 days
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Study leadership
- Kit Delgado, MD, MS · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Participants must be 18 or older
Screen positive for OUD
Bridge buprenorphine prescription (emergency department (ED) enrollment - Buprenorphine prescription at ED discharge; Bridge clinic enrollment - new buprenorphine prescription associated with on-demand or drop-in encounter
English reading ability
Have a mobile phone capable of receiving text messages
Exclusion
Not being up to date with requirements above
What this trial measures
- Engagement in any addiction treatment at 30 days of randomization31 days
Engagement in any addiction treatment within 30 days of randomization (measured on day 31)